Share buy-back programme
Medical Columbus AG
€14.10
16:30 14/11/24
St. James's Place plc
Share buy-back programme
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.
Further to the announcement made on 30 July 2024, St. James's Place plc (the Company) announces that it is commencing a share buy-back programme to repurchase its ordinary shares, subject to a maximum consideration of £32.9 million. The programme will begin on 27 August 2024 and end no later than on 31 December 2024. The sole purpose of the buy-back programme is to reduce the capital of the Company.
The programme will be carried out through an irrevocable non-discretionary agreement with J.P. Morgan Securities plc (JPMS plc), pursuant to which JPMS plc shall purchase ordinary shares as riskless principal (and not as agent of the Company) for the subsequent sale on to, and purchase by, the Company in accordance with the Company's current buy-back authority granted by shareholders at the Company's 2024 Annual General Meeting. JPMS plc will make its trading decisions in relation to the ordinary shares independently of, and uninfluenced by, the Company (including, for the avoidance of doubt, in the case of any purchases made during closed periods).
This arrangement is in accordance with the applicable UK Financial Conduct Authority's Listing Rules and the Company's general authority to repurchase shares.
Enquiries:
Hugh Taylor, Director - Investor Relations | Tel: 07818 075143 |
Roy Beale, Divisional Director - Media Relations | Tel: 07825 165329 |
Brunswick Group: |
Tel: 020 7404 5959 |
Eilis Murphy Charles Pretzlik | Email: [email protected]
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.